Scangos' Vir Biotechnology to test COVID-19 antibody 'in the summer'

When Vir Biotechnology won the Fierce 15 award a few years back, infectious disease work was something of an outlier in life science R&D. But the company was adamant it was a clear and present danger to the world and one that needed addressing.